For the quarter ending 2026-03-31, MNKD has $744,403K in assets. $803,598K in debts. $52,834K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 52,834 | 74,882 | 127,392 | 57,006 |
| Short-term investments | 81,027 | 96,464 | 132,643 | 121,979 |
| Accounts receivable, net | 28,137 | 38,367 | 17,383 | 27,142 |
| Inventory | 49,166 | 35,313 | 26,972 | 28,491 |
| Prepaid expenses and other current assets | 39,996 | 46,553 | 54,447 | 44,409 |
| Total current assets | 251,160 | 291,579 | 358,837 | 279,027 |
| Restricted cash | 747 | 745 | 743 | 741 |
| Long-term investments | - | 5,012 | 26,226 | 22,240 |
| Total property and equipment | 198,345 | 196,336 | - | - |
| Less accumulated depreciation | 115,791 | 113,913 | - | - |
| Property and equipment, net | 82,554 | 82,423 | 82,652 | 82,965 |
| Goodwill | 67,595 | 67,595 | 1,931 | 1,931 |
| Developed technology - on-body infusor | 185,708 | 190,027 | - | - |
| Ipr&d - readyflow formulation | 129,600 | 129,600 | - | - |
| Other intangible assets | 5,024 | 5,072 | 5,120 | 5,169 |
| Other assets | 22,015 | 20,129 | 19,131 | 19,624 |
| Total assets | 744,403 | 792,182 | 494,640 | 411,697 |
| Accounts payable | 16,144 | 9,034 | 7,269 | 10,257 |
| Accrued expenses and other current liabilities | 58,598 | 64,628 | 31,419 | 30,915 |
| Senior convertible notes - current | - | 36,280 | 36,224 | 36,166 |
| Liability for sale of future royalties - current | 14,010 | 14,298 | 13,841 | 13,344 |
| Contingent consideration - current | 23,877 | 21,132 | - | - |
| Financing liability - current | 10,407 | 10,328 | 10,254 | 10,190 |
| Deferred revenue current | 11,525 | 15,331 | 10,123 | 10,954 |
| Total current liabilities | 134,561 | 171,031 | 109,130 | 111,826 |
| Liability for sale of future royalties - long term | 136,561 | 136,985 | 136,913 | 137,230 |
| Financing liability - long term | 92,784 | 93,092 | 93,310 | 93,476 |
| Deferred revenue long term | 38,905 | 39,977 | 48,194 | 45,472 |
| Recognized loss on purchase commitments long term | 64,635 | 65,952 | 65,956 | 66,076 |
| Operating lease liability | 10,281 | 10,689 | 10,258 | 10,656 |
| Contingent consideration - long term | 5,146 | 5,114 | - | - |
| Milestone liabilities | 2,003 | 2,003 | 2,003 | 2,003 |
| Term loan | 318,722 | 318,361 | 73,428 | - |
| Total liabilities | 803,598 | 843,204 | 539,192 | 466,739 |
| Common stock, 0.01 par value - 800,000,000 shares authorized 308,907,331 and 307,832,587 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 3,089 | 3,078 | 3,070 | 3,063 |
| Additional paid-in capital | 3,150,295 | 3,141,741 | 3,132,249 | 3,128,631 |
| Accumulated other comprehensive (loss) income | -4 | 115 | 137 | 1,257 |
| Accumulated deficit | -3,212,575 | -3,195,956 | -3,180,008 | -3,187,993 |
| Total stockholders' deficit | -59,195 | -51,022 | -44,552 | -55,042 |
| Total liabilities and stockholders' deficit | 744,403 | 792,182 | 494,640 | 411,697 |
MANNKIND CORP (MNKD)
MANNKIND CORP (MNKD)